Related Experiment Videos
Intravenous lidocaine for status epilepticus
J Pascual1, M J Sedano, J M Polo
1Department of Medicine (Section of Neurology), National Hospital Marqués de Valdecilla, Faculty of Medicine, Santander, Spain.
Epilepsia
|September 1, 1988
Summary
Intravenous lidocaine effectively controlled convulsive status epilepticus in patients, especially elderly individuals with lung disease or those unresponsive to diazepam. This safe and effective treatment offers a valuable alternative for seizure management.
Area of Science:
- Neurology
- Pharmacology
Background:
- Convulsive status epilepticus (CSE) is a neurological emergency.
- Intravenous diazepam is a common first-line treatment but has limitations, including respiratory depression and lack of efficacy in some patients.
- Elderly patients with comorbidities like chronic obstructive lung disease (COPD) may be at higher risk for adverse effects from standard treatments.
Observation:
- Lidocaine was administered intravenously as a substitute for diazepam in eight patients with CSE.
- Patients included elderly individuals with COPD and those refractory to intravenous diazepam.
- An initial dose of 100 mg lidocaine provided transient seizure control, while 200 mg was required for effective control.
- One patient received a continuous lidocaine infusion (3.5 mg/kg/h) with positive outcomes.
- No significant adverse side effects were observed during treatment.
Findings:
- Intravenous lidocaine demonstrated efficacy in controlling convulsive status epilepticus.
- Lidocaine served as a safe alternative, particularly for patients where respiratory depression is a concern or who are unresponsive to diazepam.
- The study suggests a potential role for lidocaine as a first-line agent in specific CSE patient populations.
Implications:
- Lidocaine may be considered a viable first-line anticonvulsant therapy for CSE, especially in high-risk patient groups.
- Further research into lidocaine's anticonvulsant mechanisms and optimal dosing strategies is warranted.
- This finding could lead to improved management protocols for status epilepticus, enhancing patient safety and treatment outcomes.